US Stock MarketDetailed Quotes

ANIX Anixa Biosciences

Watchlist
  • 3.130
  • +0.190+6.46%
Close Jul 22 16:00 ET
  • 3.060
  • -0.070-2.24%
Post 17:45 ET
100.18MMarket Cap-8459P/E (TTM)

Anixa Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
Total revenue
0
0
210K
0
0
210K
0
0
0
0
Operating revenue
--0
--0
--210K
--0
--0
--210K
--0
--0
--0
--0
Cost of revenue
0
161K
0
0
161K
0
0
0
Gross profit
0
49K
0
0
49K
0
0
0
Operating expense
32.89%3.47M
41.20%3.61M
-20.29%11.06M
-15.46%3.05M
1.68%2.84M
-27.31%2.61M
-34.12%2.56M
4.61%13.88M
-11.46%3.61M
-36.26%2.8M
Selling and administrative expenses
13.04%1.82M
51.88%2.26M
-12.28%6.29M
-25.36%1.44M
29.88%1.76M
-13.11%1.61M
-27.13%1.49M
1.40%7.17M
1.10%1.92M
-39.13%1.35M
-General and administrative expense
13.04%1.82M
51.88%2.26M
-12.28%6.29M
-25.36%1.44M
29.88%1.76M
-13.11%1.61M
-27.13%1.49M
1.40%7.17M
1.10%1.92M
-39.13%1.35M
Research and development costs
64.93%1.65M
26.31%1.35M
-28.85%4.77M
-4.15%1.62M
-24.71%1.09M
-42.48%998K
-41.89%1.07M
8.29%6.7M
-22.46%1.69M
-33.32%1.45M
Operating profit
-35.43%-3.47M
-41.20%-3.61M
20.64%-11.01M
15.46%-3.05M
-1.68%-2.84M
28.67%-2.56M
34.12%-2.56M
-5.63%-13.88M
11.48%-3.61M
36.26%-2.8M
Net non-operating interest income expense
13.44%287K
57.92%319K
939.42%1.08M
312.50%330K
1,245.45%296K
25,200.00%253K
20,100.00%202K
5,100.00%104K
80K
22K
Non-operating interest income
13.44%287K
57.92%319K
939.42%1.08M
312.50%330K
1,245.45%296K
25,200.00%253K
20,100.00%202K
5,100.00%104K
--80K
--22K
Other net income (expense)
Income before tax
-37.84%-3.18M
-39.76%-3.29M
27.89%-9.93M
22.90%-2.72M
8.18%-2.55M
35.70%-2.31M
39.31%-2.35M
-4.90%-13.77M
13.31%-3.53M
36.76%-2.78M
Income tax
Net income
-37.84%-3.18M
-39.76%-3.29M
27.89%-9.93M
22.90%-2.72M
8.18%-2.55M
35.70%-2.31M
39.31%-2.35M
-4.90%-13.77M
13.31%-3.53M
36.76%-2.78M
Net income continuous Operations
-37.84%-3.18M
-39.76%-3.29M
27.89%-9.93M
22.90%-2.72M
8.18%-2.55M
35.70%-2.31M
39.31%-2.35M
-4.90%-13.77M
13.31%-3.53M
36.76%-2.78M
Minority interest income
-115.79%-41K
-9.38%-35K
32.39%-119K
41.51%-31K
-27.59%-37K
56.82%-19K
36.00%-32K
-1.15%-176K
8.62%-53K
46.30%-29K
Net income attributable to the parent company
-37.19%-3.14M
-40.18%-3.26M
27.83%-9.81M
22.61%-2.69M
8.56%-2.51M
35.44%-2.29M
39.36%-2.32M
-4.95%-13.6M
13.38%-3.48M
36.64%-2.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-37.19%-3.14M
-40.18%-3.26M
27.83%-9.81M
22.61%-2.69M
8.56%-2.51M
35.44%-2.29M
39.36%-2.32M
-4.95%-13.6M
13.38%-3.48M
36.64%-2.75M
Basic earnings per share
-42.86%-0.1
-25.00%-0.1
28.89%-0.32
25.00%-0.09
11.11%-0.08
41.67%-0.07
38.46%-0.08
0.00%-0.45
7.69%-0.12
35.71%-0.09
Diluted earnings per share
-42.86%-0.1
-25.00%-0.1
28.89%-0.32
25.00%-0.09
11.11%-0.08
41.67%-0.07
38.46%-0.08
0.00%-0.45
7.69%-0.12
35.71%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022
Total revenue 00210K00210K0000
Operating revenue --0--0--210K--0--0--210K--0--0--0--0
Cost of revenue 0161K00161K000
Gross profit 049K0049K000
Operating expense 32.89%3.47M41.20%3.61M-20.29%11.06M-15.46%3.05M1.68%2.84M-27.31%2.61M-34.12%2.56M4.61%13.88M-11.46%3.61M-36.26%2.8M
Selling and administrative expenses 13.04%1.82M51.88%2.26M-12.28%6.29M-25.36%1.44M29.88%1.76M-13.11%1.61M-27.13%1.49M1.40%7.17M1.10%1.92M-39.13%1.35M
-General and administrative expense 13.04%1.82M51.88%2.26M-12.28%6.29M-25.36%1.44M29.88%1.76M-13.11%1.61M-27.13%1.49M1.40%7.17M1.10%1.92M-39.13%1.35M
Research and development costs 64.93%1.65M26.31%1.35M-28.85%4.77M-4.15%1.62M-24.71%1.09M-42.48%998K-41.89%1.07M8.29%6.7M-22.46%1.69M-33.32%1.45M
Operating profit -35.43%-3.47M-41.20%-3.61M20.64%-11.01M15.46%-3.05M-1.68%-2.84M28.67%-2.56M34.12%-2.56M-5.63%-13.88M11.48%-3.61M36.26%-2.8M
Net non-operating interest income expense 13.44%287K57.92%319K939.42%1.08M312.50%330K1,245.45%296K25,200.00%253K20,100.00%202K5,100.00%104K80K22K
Non-operating interest income 13.44%287K57.92%319K939.42%1.08M312.50%330K1,245.45%296K25,200.00%253K20,100.00%202K5,100.00%104K--80K--22K
Other net income (expense)
Income before tax -37.84%-3.18M-39.76%-3.29M27.89%-9.93M22.90%-2.72M8.18%-2.55M35.70%-2.31M39.31%-2.35M-4.90%-13.77M13.31%-3.53M36.76%-2.78M
Income tax
Net income -37.84%-3.18M-39.76%-3.29M27.89%-9.93M22.90%-2.72M8.18%-2.55M35.70%-2.31M39.31%-2.35M-4.90%-13.77M13.31%-3.53M36.76%-2.78M
Net income continuous Operations -37.84%-3.18M-39.76%-3.29M27.89%-9.93M22.90%-2.72M8.18%-2.55M35.70%-2.31M39.31%-2.35M-4.90%-13.77M13.31%-3.53M36.76%-2.78M
Minority interest income -115.79%-41K-9.38%-35K32.39%-119K41.51%-31K-27.59%-37K56.82%-19K36.00%-32K-1.15%-176K8.62%-53K46.30%-29K
Net income attributable to the parent company -37.19%-3.14M-40.18%-3.26M27.83%-9.81M22.61%-2.69M8.56%-2.51M35.44%-2.29M39.36%-2.32M-4.95%-13.6M13.38%-3.48M36.64%-2.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -37.19%-3.14M-40.18%-3.26M27.83%-9.81M22.61%-2.69M8.56%-2.51M35.44%-2.29M39.36%-2.32M-4.95%-13.6M13.38%-3.48M36.64%-2.75M
Basic earnings per share -42.86%-0.1-25.00%-0.128.89%-0.3225.00%-0.0911.11%-0.0841.67%-0.0738.46%-0.080.00%-0.457.69%-0.1235.71%-0.09
Diluted earnings per share -42.86%-0.1-25.00%-0.128.89%-0.3225.00%-0.0911.11%-0.0841.67%-0.0738.46%-0.080.00%-0.457.69%-0.1235.71%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg